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Polarized epithelial cells have functionally distinct apical and
basolateral membranes through which they communicate with
external and internal bodily environments, respectively. The
establishment and maintenance of this asymmetric structure
depend on polarized trafficking of specific cargos, but the pre-
cise molecular mechanism is incompletely understood. We pre-
viously showed that Rab35, a member of the Rab family small
GTPases, differentially regulates the trafficking of an apical
cargo, podocalyxin (PODXL), in two-dimensional (2D) and
three-dimensional (3D) Madin–Darby canine kidney (MDCK)
II cell cultures through specific interactions with two distinct
effectors, OCRL inositol polyphosphate-5-phosphatase (OCRL)
and ArfGAP with coiled-coil, ankyrin repeat and pleckstrin ho-
mology domains 2 (ACAP2), respectively. However, whether the
upstream regulators of Rab35 also differ depending on the cul-
ture conditions remains completely unknown. Here, we investi-
gated four known guanine nucleotide exchange factors (GEFs)
of Rab35, namely DENN domain– containing 1A (DENND1A),
DENND1B, DENND1C, and folliculin (FLCN), and demon-
strate that DENND1A and FLCN exhibit distinct requirements
for Rab35-dependent PODXL trafficking under the two culture
conditions. In 3D cell cultures, only DENDN1A-knockout cysts
exhibited the inverted localization of PODXL similar to that of
Rab35-knockout cysts. Moreover, the DENN domain, harboring
GEF activity toward Rab35, was required for proper PODXL
trafficking to the apical membrane. By contrast, FLCN-knock-
down cells specifically accumulated PODXL in actin-rich struc-
tures similar to the Rab35-knockdown cells in 2D cell cultures.
Our findings indicate that two distinct functional cascades of
Rab35, the FLCN-Rab35-OCRL and the DENND1A-Rab35-
ACAP2 axes, regulate PODXL trafficking in 2D and 3D MDCK
II cell cultures, respectively.
Polarized epithelial cells have morphologically and function-
ally distinct apical and basolateral membranes, each of which
contains specific proteins and lipids. However, the precise
molecular mechanism of polarized cargo trafficking to the api-
cal or basolateral membrane remains largely unknown (1). Rab
small GTPases are critical regulators of intracellular membrane
trafficking in eukaryotic cells (2–5). An active form of Rab local-
izes to specific membranes or subcellular compartments and
regulates various types (or steps) of membrane trafficking, such
as polarized trafficking, by recruiting specific effector(s). We
previously performed a comprehensive screening for Rabs that
regulate the trafficking of podocalyxin (PODXL),3 an apical
cargo protein, and epithelial cell polarity formation in two-di-
mensional (2D) and three-dimensional (3D) Madin–Darby
canine kidney (MDCK) II cell cultures (6, 7) and found that
various Rab isoforms regulate PODXL transcytosis at different
trafficking steps. Of particular interest was that whereas the
route of PODXL transcytosis is seemingly the same between the
two culture conditions, Rab35 differentially regulated PODXL
trafficking, depending on the culture conditions. In 3D cysts,
Rab35 knockout (KO) or knockdown (KD) caused an “inverted
cyst” phenotype, in which PODXL remained on the outer mem-
brane (6, 8), whereas in 2D cell cultures, Rab35 depletion
caused PODXL accumulation in actin-rich structures during
the early stage of polarization (6). Intriguingly, however, these
Rab35-KO phenotypes were observed in the early stage of epi-
thelial polarization, and PODXL was transported to the apical
membrane in fully polarized cells, suggesting the existence of
an alternative Rab35-independent mechanism of PODXL traf-
ficking (6). Moreover, two distinct Rab35 effectors, OCRL ino-
sitol polyphosphate-5-phosphatase (OCRL) and ArfGAP with
coiled-coil, ankyrin repeat and pleckstrin homology domains 2
(ACAP2; also called centaurin-2), were found to be required
for PODXL trafficking under 2D and 3D culture conditions,
respectively (6). These results raised the possibility that the
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upstream regulators of Rab35 are also different between the
two culture conditions.
The activation of Rab is thought to be spatiotemporally reg-
ulated by its specific guanine nucleotide exchange factors
(GEFs), and four Rab35–GEFs have been reported so far: three
DENN domain– containing 1 (DENND1) family proteins and
folliculin (FLCN). The DENND1 family consists of three para-
logs, DENND1A–C/connecdenn 1–3, all of which have a
DENN domain that harbors GEF activity toward Rab35 in their
N-terminal regions (9). The C-terminal regions are relatively
less conserved and contain several unique domains and motifs,
suggesting the functional diversity of the DENND1 family
members. Both DENND1A and DENND1B contain clathrin–
and AP-2– binding motifs and have been shown to be involved
in clathrin-mediated endocytosis, endosome-to-trans-Golgi
network trafficking, and the recycling of certain receptors (10 –
16). By contrast, DENND1C has a unique actin-binding motif and
is required for the regulation of actin dynamics (17). Another
Rab35–GEF, FLCN (18), also contains a DENN-like domain that
harbors GEF activity toward Rab35 (19, 20), but FLCN is also
known to act as a GTPase-activating protein (GAP) for other small
GTPases, such as RagC/D (21) and Rab7A (22). Despite the pres-
ence of four different types of Rab35–GEFs in terms of their
domain organization, their involvement in polarized trafficking in
epithelial cells is completely unknown.
In this study, we investigated which Rab35–GEFs, specifi-
cally DENND1 proteins, are required for the transcytosis of
PODXL in 2D and 3D MDCK II cell cultures by analyzing the
phenotypes of each Rab35–GEF depletion. We found that only
DENND1A-KO causes an inverted cyst phenotype similar to
that of Rab35-KO cells. By contrast, none of the DENND1 fam-
ily proteins are involved in PODXL trafficking in 2D cell cul-
tures; instead, FLCN-KD phenocopied Rab35 deficiency (i.e.
PODXL accumulation in actin-rich structures) in 2D cell cul-
tures. Our findings suggest that Rab35-dependent PODXL
transcytosis is differentially regulated by its upstream GEFs
between 2D and 3D cell cultures.
Results
Active Rab35 regulates PODXL trafficking
PODXL is a highly glycosylated transmembrane protein that
is widely used as an apical membrane marker (23, 24). During
the polarization of MDCK II cells, PODXL is actively transcy-
tosed toward the nascent apical membrane (Fig. 1A; modified
from Ref. 6). In a previous study, we showed that Rab35 differ-
entially regulates PODXL trafficking, depending on the culture
conditions. When Rab35-depleted MDCK II cells were plated
on Matrigel (i.e. a 3D culture), they showed an “inverted cyst”
phenotype, in which PODXL remained on the outer membrane
during the 3D cyst formation (Fig. 1A, top row) (6, 8). On the
other hand, when Rab35-depleted cells were plated on
uncoated glass-bottom dishes (i.e. a 2D culture), they showed
PODXL accumulation in actin-rich structures during the early
stage of 2D monolayer formation (Fig. 1A, bottom row) (6). To
confirm whether active Rab35 is necessary for the regulation of
PODXL trafficking, we first performed KO-rescue experiments
using constitutively active and negative mutants of Rab35
(Rab35-Q67L (QL) and -S22N (SN), respectively). Rab35-KO
cells and those stably expressing enhanced GFP (EGFP)-Rab35
(WT, QL, or SN) were cultured under 2D and 3D culture con-
ditions and were fixed once the Rab35-KO phenotypes became
observable (42 h after plating for the 3D cultures and 3 h after
plating for the 2D cultures) (Fig. 1A), followed by the immuno-
staining of PODXL. The results showed that the expression of
Rab35-QL clearly rescued the Rab35-KO phenotypes under
both culture conditions, similar to the results of Rab35-WT
expression, whereas the expression of Rab35-SN failed to
restore PODXL localization (Fig. 1, B and C). We thus con-
cluded that Rab35 regulates PODXL trafficking when it is in an
active state regardless of the culture conditions.
DENND1A, but not DENND1B or DENND1C, is specifically
required for PODXL trafficking in 3D cysts
The activation of Rabs is generally thought to be regulated by
their specific GEFs (25, 26). Because Rab35 differentially regu-
lates PODXL trafficking in 2D and 3D cell cultures, we hypoth-
esized that distinct Rab35–GEFs are required for Rab35 activa-
tion, depending on the culture conditions. We first focused on
the well-known Rab35–GEFs, the DENND1 family proteins
(9 –11), because their C-terminal regions are relatively diver-
gent in addition to the conserved N-terminal DENN domain,
which exerts Rab35–GEF activity in vitro (Fig. 2A). Actually,
the localization of EGFP-tagged DENND1 family proteins was
different in both 2D and 3D MDCK II cell cultures (Fig. S1). The
results of a quantitative RT-PCR analysis indicated that all of
the DENND1 family genes were expressed in MDCK II cells
(the relative mRNA expression level was DENND1B (1.755 
0.151, mean  S.E.)  DENND1A (1.0)  DENND1C (0.358 
0.179); Fig. S2A). To investigate the possible involvement of
DENND1A–C in PODXL trafficking, we used a genome-edit-
ing technology to establish each DENND1-KO MDCK II cell
line. We confirmed that all indels occurred within the DENN
domain– coding sequence to disrupt the Rab35–GEF function
of DENND1 proteins (Fig. S2, B and C). The loss of DENND1A
protein in DENND1A-KO cells was also confirmed by immu-
noblotting with anti-DENND1A antibody (Fig. 2B). When
these KO cells together with the parental and Rab35-KO cells
were cultured under 3D culture conditions, only the
DENND1A-KO cysts showed the inverted localization of
PODXL, similar to the Rab35-KO cysts (Fig. 2C). By contrast,
DENND1B-KO (#2 and #11) and DENND1C-KO cells (#7 and
#20; two independent clones) formed 3D cysts with normal
PODXL localization, similar to parental MDCK II cells (Fig. 2C)
(data not shown). Because the inverted PODXL phenotype of
the DENND1A-KO clone (#45) was also observed in another
independent DENND1A-KO clone (#9) and because the phe-
notypes of both clones were clearly rescued by the stable
expression of mouse DENND1A (Fig. 2D), these results repre-
sent a bona fide phenotype induced by the specific loss of the
DENND1A gene that is not caused by an off-target effect of
guide RNA or by clonal variations among cell lines. These
results strongly suggest that only DENND1A is required for
PODXL trafficking in 3D cell cultures.
To further confirm the specific involvement of DENND1A in
PODXL trafficking in 3D cysts, we next asked whether DENND1B
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or DENND1C can rescue the phenotype of DENND1A-KO cells.
Consistent with the result of the DENND1B/1C-KO analysis
described above, neither the stable expression of human
DENND1B nor DENND1C in DENND1A-KO cells rescued the
inverted PODXL phenotype (Fig. 3A and Fig. S3A), even though
equivalent amounts of exogenous DENND1 family proteins were
expressed in DENND1A-KO cells (Fig. 3B). These results allowed
us to conclude that DENND1A is specifically required for PODXL
trafficking in 3D cysts.
The N-terminal DENN domain of DENND1A is required for
PODXL trafficking in 3D cysts
To clarify whether DENND1A regulates PODXL trafficking
through the activation of Rab35 in 3D cysts, we performed a
Figure 1. Active Rab35 is required for PODXL trafficking under 2D and 3D culture conditions. A, schematic representation of PODXL localization during 3D
cyst and 2D monolayer formation of MDCK II cells (modified from Ref. 6). In a 3D Rab35-KO cell culture, PODXL (green) remained on the outer membrane at 42 h
after plating (Inverted PODXL) (top row, 3D culture). In a 2D Rab35-KO cell culture, endocytosed PODXL from the membrane attaching to the bottom plane of the
dish localized and accumulated on actin-rich structures (red) at 3 h after plating (PODXL with actin) (bottom row, 2D culture). B, Rab35-KO (#20) and its rescued
cells (EGFP-Rab35 (WT, QL, or SN; shown in green)) were plated on Matrigel and fixed at 42 h after plating. The cells were stained for PODXL (red) and DAPI
(blue), followed by counting of the inverted PODXL (30 cysts/condition). The arrowheads show PODXL localized on the outer membrane. Scale bars, 10 m. The
graph shows the means and S.E. (error bars) of three independent experiments. ***, p  0.001; NS, not significant (Dunnett’s test). C, Rab35-KO (#20) and its
rescued cells (EGFP-Rab35 (WT, QL, or SN)) were plated on glass-bottom dishes and fixed at 3 h after plating. The cells were stained for PODXL (green), actin
(red), and DAPI (blue), followed by counting of cells with co-localized PODXL and actin (30 cells/condition). The confocal xz-plane (top) and the xy-plane (bottom)
are shown. The arrowheads show PODXL co-localizing with actin. Scale bars, 10 m. The graph shows the means and S.E. (error bars) of four independent
experiments. *, p  0.05; **, p  0.01; NS, not significant (Dunnett’s test).
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rescue experiment using a DENN domain–truncated mutant
(named DENND1A(DENN)) of DENND1A. As expected, the
stable expression of the DENN mutant did not rescue the
inverted PODXL localization in DENND1A-KO cysts (Fig. 4 (A
and B) and Fig. S3B). By contrast, the DENN domain of
DENND1A (named DENND1A(DENN)) alone was able to res-
cue the inverted PODXL localization despite its cytosolic local-
ization (Fig. 4 and Fig. S4). These results suggest that the acti-
vation of Rab35 by the DENN domain of DENND1A is
responsible for PODXL trafficking under 3D culture conditions.
Because the DENN domain of all DENND1 family proteins
basically has Rab35–GEF activity in vitro (15), we hypothesized
that the C-terminal domain of DENND1A is also required for
efficient activation of Rab35 during PODXL trafficking in 3D
cysts. To test this hypothesis, we further prepared DENND1
chimera proteins, named DENND1B/1A (DENND1B-DENN 
DENND1A-DENN) and DENND1C/1A (Fig. 4C), and per-
formed a rescue experiment. The results showed that the
inverted PODXL phenotype in DENND1A-KO cysts was
clearly rescued by the expression of either DENND1B/1A or
Figure 2. DENND1A-KO, but not DENND1B-KO or DENND1C-KO, induces the inverted localization of PODXL in 3D cysts. A, schematic representation of
mouse DENND1 family proteins. The domains and motifs are depicted according to previous reports (15, 17) and the UniProtKB (DENND1A, Q8K382; DENND1B,
Q3U1T9; DENND1C, Q8CFK6). uDENN, upstream DENN; cDENN, central/core DENN; dDENN, downstream DENN; FXDXF, AP-2 -ear platform subdomain–
binding motif; CB, clathrin heavy chain– binding motif; WXXF-acidic, AP-2 -ear sandwich subdomain– binding motif; AA, amino acids. B, lysates of parental cells
and two DENND1A-KO cells (#9 and #45) were analyzed by immunoblotting (IB) with anti-DENND1A and anti--actin antibodies. The arrowhead indicates the
position of endogenous DENND1A. The asterisks indicate nonspecific bands of the primary antibody. C, parental, Rab35-KO, DENND1A-KO, DENND1B-KO, and
DENND1C-KO cells were plated on Matrigel and fixed at 42 h after plating. The cells were stained for PODXL (green) and DAPI (blue), followed by counting of the
inverted PODXL (30 cysts/condition). The arrowheads show PODXL localizing on the outer membrane. Scale bars, 10 m. The graph shows the means and S.E.
(error bars) of three independent experiments. ***, p  0.001; NS, not significant (Dunnett’s test). D, parental cells, DENND1A-KO (#9 and #45) cells, and their
rescued cells (Myc-DENND1A) were plated on Matrigel and fixed at 42 h after plating, followed by counting of the inverted PODXL (30 cysts/condition). The
arrowheads show PODXL localizing on the outer membrane. Scale bars, 10 m. The graph shows the means and S.E.(error bars) of three independent
experiments. ***, p  0.001; **, p  0.01 (Tukey’s test).
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DENND1C/1A, the same as the DENND1A expression (Fig. 4,
D and E). Thus, the C-terminal domain of DENND1A also con-
tributes to the Rab35-dependent PODXL trafficking in 3D
cysts.
DENND1 family proteins are not involved in PODXL trafficking
under 2D culture conditions
To determine the functional diversity of the DENND1 family
proteins in PODXL trafficking even in 2D monolayer forma-
tion, we further investigated whether DENND1A–C are
required for PODXL trafficking under 2D culture conditions.
To our surprise, however, none of the DENND1-KO cells
showed an accumulation of PODXL in actin-rich structures,
which is a characteristic phenotype of Rab35-KO cells in 2D cell
cultures (Fig. 5). Therefore, another Rab35–GEF protein other
than the DENND1 family proteins is probably required for
PODXL trafficking under 2D culture conditions.
FLCN regulates PODXL trafficking under 2D culture conditions
Finally, we focused on FLCN, another type of Rab35–GEF,
which also contains a DENN-like domain (19, 20), and investi-
gated its involvement in PODXL trafficking in 2D cell cultures.
To this end, we knocked down endogenous FLCN using two
independent siRNAs (#1 and #2). Parental MDCK II cells that
had been transfected with control siRNA or siRNAs against
FLCN (or Rab35 as a positive control) were fixed at 3 h after
replating on glass-bottom dishes, followed by immunostaining
for PODXL. As a result, FLCN-KD cells, but not control cells,
showed PODXL accumulation in actin-rich structures, similar
to the Rab35-KD cells (Fig. 6, A and B). The observed effect was
clearly rescued by the stable expression of mouse FLCN (Fig. 6,
C and D), ruling out the possibility of an off-target effect of
siRNAs. By contrast, no apparent phenotype was observed in
FLCN-KD cells for 3D cell cultures (Fig. S5). We thus con-
cluded that FLCN is required for Rab35-dependent PODXL
trafficking under 2D culture conditions.
Discussion
We previously found that Rab35 differentially regulates
PODXL trafficking in 2D and 3D MDCK cell cultures
through its interactions with two downstream effectors,
OCRL and ACAP2, respectively (6). In the present study, we
presented new evidence indicating that distinct Rab35–
GEFs (upstream regulators of Rab35) regulate PODXL traf-
ficking under two culture conditions. Namely, DENND1A is
specifically required for PODXL trafficking in 3D cysts (Figs.
2–5; DENND1A deficiency caused inverted PODXL local-
ization), whereas FLCN is required for PODXL trafficking in
2D cell cultures (Fig. 6; FLCN deficiency caused PODXL
accumulation in actin-rich structures). Our findings indicate
that two functional GEF-Rab-effector cascades (i.e. the
FLCN-Rab35-OCRL axis and the DENND1A-Rab35-
ACAP2 axis) regulate PODXL trafficking during epithelial
polarization under 2D and 3D culture conditions, respec-
tively (Fig. 7).
How does DENND1A specifically regulate PODXL traffick-
ing in 3D cell cultures? One possible mechanism is the differ-
ence in the gene expression between 2D and 3D cell cultures
(27). However, this mechanism is unlikely because the mRNA
expression levels of DENND1A–C and FLCN are reportedly
unaltered between 2D and 3D cell cultures (27). Moreover, the
DENND1A–C mRNA expression levels were comparable in
MDCK II cells (Fig. S2A). Thus, a high gene expression level
would not simply explain the specific involvement of
DENND1A in PODXL trafficking in 3D cell cultures (or FLCN
in 2D cell cultures).
Because it has been proposed that the activation and local-
ization of Rabs are generally defined by their upstream GEFs
(28, 29), another possible mechanism is the specific localization
of Rab35–GEFs during the polarization of MDCK II cells. Actu-
ally, different subcellular localizations of DENND1 family pro-
teins have previously been reported in nonepithelial cells (10,
11, 15, 17). We especially noted the fact that only DENND1A
was specifically localized near the apical membrane, where
PODXL (and Rab35) is localized in 3D cysts (Fig. S1A) (6, 8). By
contrast, DENND1C seemed to become localized in the baso-
lateral membrane, and DENND1B mostly showed a cytosolic
localization in addition to its weak association with mem-
branes. Moreover, FLCN showed a cytosolic localization (Fig.
Figure 3. DENND1A is specifically required for PODXL trafficking in 3D cysts. A, parental cells, DENND1A-KO (#45) cells, and its rescued cells (6FLAG-
tagged DENND1A, DENND1B, or DENND1C) were plated on Matrigel and fixed at 42 h after plating, followed by counting of the inverted PODXL (30 cysts/
condition). The graph shows the means and S.E. (error bars) of three independent experiments. **, p  0.01; NS, not significant (Tukey’s test). Representative
images are shown in Fig. S3A. B, lysates of the cells used in A were analyzed by immunoblotting (IB) with anti-FLAG and anti--actin antibodies. The asterisks
show the predicted 3FLAG-tagged SpCas9 degradation products, because an 160-kDa protein was detected by immunoblotting with anti-FLAG antibody
in DENND1A-KO #45 cells, but not in parental cells (data not shown).
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S1A). Thus, it seems likely that the specific localization of
DENND1A at the apical membrane of 3D cysts specifically
regulates PODXL trafficking. Actually, DENND1B/1A and
DENND1C/1A chimera proteins, but not DENND1B or
DENND1C, can rescue the inverted PODXL phenotype in
DENND1A-KO cells (Fig. 4D), strongly supporting the impor-
tance of the C-terminal domain of DENND1A in PODXL
trafficking.
The apical localization of DENND1A should be mediated by
its C-terminal domain, because the DENND1A(DENN)
mutant still has an ability to localize near the apical membrane
(Fig. S4), although the DENN mutant itself did not rescue the
inverted PODXL phenotype (Fig. 4A). Consistent with our
observation, DENND1A is known to localize to clathrin-coated
vesicles via its several clathrin– and AP-2– binding motifs (Fig.
2A) (10, 15), whereas DENND1B only partially localizes to
clathrin-coated vesicles despite having clathrin– and AP-2–
binding motifs in its C-terminal region (15). Actually, EGFP-
tagged DENND1A, but not DENND1B or DENND1C, was
strongly co-localized with monomeric Strawberry (mStr)-
tagged clathrin light chain in 2D and 3D MDCK cell cultures
(Fig. S1, C and D). Whether or not DENND1A is recruited near
Figure 4. The N-terminal DENN domain of DENND1A is required for PODXL trafficking in 3D cysts. A, DENND1A-KO (#9) and its rescued cells (Myc-
DENND1A (WT, DENN, or DENN)) were plated on Matrigel and fixed at 42 h after plating, followed by counting of the inverted cysts (30 cysts/condition). The
graph shows the means and S.E. (error bars) of three independent experiments. ***, p  0.001; NS, not significant (Dunnett’s test). Representative images are
shown in Fig. S3B. B, lysates of the cells used in A were analyzed by immunoblotting (IB) with anti-Myc and anti--actin antibodies. The additional higher bands
(asterisks) in the blots presumably result from post-translational modifications, such as phosphorylation (30). Alternatively, the DENN domain of DENND1A
could form an SDS-insensitive dimer. C, schematic representation of DENND1B/1A and DENND1C/1A chimera proteins. The DENND1B/1A (or DENND1C/1A)
chimera protein consists of the DENN domain of human DENND1B (DENND1B-DENN) (or DENND1C (DENND1C-DENN)) fused with the C-terminal part of mouse
DENND1A (DENND1A-DENN). D, DENND1A-KO (#45) and its rescued cells (6FLAG-tagged DENND1A, DENND1B/1A, or DENND1C/1A) were plated on
Matrigel and fixed at 42 h after plating, followed by counting of the inverted PODXL (30 cysts/condition). The graph shows the means and S.E. (error bars) of
three independent experiments. ***, p  0.001; **, p  0.01; NS, not significant (Tukey’s test). Representative images are shown in Fig. S3C. E, lysates of the cells
used in D were analyzed by immunoblotting with anti-FLAG and anti--actin antibodies. The asterisk shows the predicted 3FLAG-tagged SpCas9 degrada-
tion products.
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the apical membrane by means of clathrin/AP-2 binding awaits
further investigation.
Although we favored the above possibility that the apical
membrane localization of DENND1A is a prerequisite for the
activation of Rab35 and PODXL trafficking, our other finding
that the cytosolically expressed DENN domain alone can rescue
the inverted PODXL phenotype in DENND1A-KO cells (Fig. 4)
seemed to be inconsistent with this possibility. However, the
apparent discrepancy can be explained by a previously reported
autoinhibition mechanism of DENND1A on Rab35–GEF activ-
ity: the Rab35–GEF activity of DENND1A is autoinhibited by
an intramolecular interaction between the DENN domain and
its downstream region, and the isolated DENN domain shows a
2–3 times greater Rab35–GEF activity than the full-length pro-
tein does in vitro (30). We thus speculated that such a hyper-
active GEF fragment would promiscuously activate Rab35
throughout the cytoplasm. Because it has been proposed that
the phosphorylation of DENND1A regulates its Rab35–GEF
activity through an intramolecular interaction (30), the extra-
cellular matrix– dependent phosphorylation of DENND1A
might locally activate Rab35 near the apical membrane. Further
extensive research is necessary to determine the regulatory
mechanism for the Rab35–GEF activity of DENND1A.
As noted above, because the DENN domain of DENND1B
and DENND1C possesses Rab35–GEF activity, it is possible
that an excessively high expression level of DENND1B
or DENND1C could support PODXL trafficking in
DENND1A-KO 3D cysts. As expected, forced overexpression
of DENND1B or DENND1C (30 times higher than endoge-
nous DENND1A) was able to rescue DENND1A-KO cells (Fig.
S6), although such a condition is physiologically irrelevant. We
speculate that some portions of overexpressed DENND1B (or
DENND1C) localize in cytosol, which would activate Rab35
just near the apical region to support apical localization of
PODXL.
In contrast to 3D cysts, FLCN was found to be specifically
required for the Rab35-dependent PODXL trafficking in 2D
cell cultures (Fig. 6). Although the role of FLCN in the endo-
cytic/recycling pathway in mammals is poorly understood, a
previous study on Caenorhabditis elegans development showed
that both Rab35 and FLCN-1 (C. elegans FLCN) are required
for the maturation and clearance of phagosomes that contain
apoptotic cells (31). Both Rab35 and FLCN-1 transiently local-
ize to nascent phagosomes, and the loss of Rab35 delays
PI(4,5)P2 removal from phagosomal membranes. Notably, the
loss of OCRL-1 in C. elegans also results in the persistent accu-
mulation of PI(4,5)P2 on phagosomal membranes (32), suggest-
ing that the FLCN-1-Rab35-OCRL-1 axis regulates phospho-
inositide metabolism during phagosome maturation. Under
our experimental conditions, EGFP/mStr-tagged FLCN
seemed to be diffusely present throughout the cytoplasm and
did not show any robust vesicular localization in MDCK II cells
(Fig. S1); however, it is still possible that FLCN very weakly and
transiently associates with PODXL-containing endosomes as
with phagosomes in C. elegans. Further investigation is needed
to specify the exact time points and places at which FLCN func-
tions during 2D epithelial polarization.
The main differences between 2D and 3D culture conditions
are the existence of the extracellular matrix and substrate stiff-
ness (i.e. hard coverslips versus soft gels). Because epithelial
tissues generally develop in the presence of the soft extracellu-
lar matrix, the 3D cell culture is thought to be more suitable to
mimic the normal physiological conditions. However, because
tumors are known to be much stiffer than normal tissues, the
phenotypes observed in the 2D cell culture may reflect the cel-
lular behaviors in such pathological environments. Therefore,
our findings suggest the physiological roles of DENND1A and
FLCN in normal tissue development and tumor progression/
suppression, respectively, and further research will be needed
to determine the physiological roles of these Rab35–GEFs.
In summary, we have investigated the regulation of PODXL
trafficking by Rab35–GEFs in 2D and 3D epithelial cell cultures,
and we discovered that FLCN and DENND1A differentially
regulate PODXL trafficking in 2D monolayer formation and 3D
cyst formation, respectively. Our findings indicate that two dis-
tinct Rab35-dependent PODXL-trafficking pathways are pres-
ent in polarizing epithelial cells, depending on the extracellular
environments.
Figure 5. DENND1 family proteins are not required for PODXL trafficking under 2D culture conditions. Parental, Rab35-KO, DENND1A-KO, DENND1B-KO,
and DENND1C-KO cells were plated on glass-bottom dishes and fixed at 3 h after plating. The cells were stained for PODXL (green), actin (red), and DAPI (blue),
followed by counting of cells with co-localized PODXL and actin. The arrowheads show PODXL co-localized with actin. Scale bars, 10 m. The graph shows the
means and S.E. (error bars) of three independent experiments. *, p  0.05; NS, not significant (Dunnett’s test).
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Anti-PODXL rabbit polyclonal antibody was prepared as
described previously (6). Anti-DENND1A rabbit polyclonal
antibody was raised against a synthetic peptide, CVEQLR-
RQWETFE, which corresponds to the C terminus of mouse/
human/canine DENND1A (underlined), with an artificial cys-
teine being added to its N terminus. The following antibodies
were obtained commercially: anti--actin mouse mAb
(Applied Biological Materials, #G043), anti-FLAG (M2) mouse
mAb (Sigma–Aldrich, #F1804), anti-Myc (9E10) mouse mAb
(Santa Cruz Biotechnology, Inc., #sc-40), anti-FLCN rabbit
Figure 6. FLCN regulates PODXL trafficking under 2D culture conditions. A, parental cells that had been transfected with control siRNA (siControl), siRNAs
against Rab35 (siRab35), or FLCN (two independent target sites: #1 and #2) (siFLCN) were plated on glass-bottom dishes and fixed at 3 h after plating, followed
by counting of cells with co-localized PODXL and actin (30 cells/condition). The arrowheads show PODXL co-localizing with actin. Scale bars, 10 m. The graph
shows the means and S.E. (error bars) of four independent experiments. *, p  0.05; **, p  0.01 (Dunnett’s test). B, KD efficiency of Rab35 and FLCN as revealed
by immunoblotting (IB) with anti-FLCN, anti-Rab35, and anti--actin antibodies. The arrowhead indicates the position of endogenous FLCN. The asterisk
indicates a nonspecific band of the primary antibody. C, parental cells and Myc-FLCN– expressing cells (Myc-FLCN) that had been transfected with control
siRNA or siRNA against FLCN (#1) were plated on glass-bottom dishes and fixed at 3 h after plating, followed by counting of cells with co-localized PODXL and
actin (30 cells/condition). The graph shows the means and S.E. (error bars) of three independent experiments. *, p  0.05; NS, not significant (Tukey’s test). The
arrowhead shows PODXL co-localizing with actin. D, lysates of the cells used in C were analyzed by immunoblotting with anti-FLCN and anti--actin antibodies.
Note that endogenous (endo) FLCN, but not exogenous mouse FLCN, were efficiently knocked down by the siFLCN #1. Because knockdown of endogenous
FLCN in Myc-FLCN– expressing cells was not observed, presumably because of the existence of the degradation product of Myc-FLCN, the decrease of
endogenous FLCN mRNA in parental and Myc-FLCN– expressing MDCK II cells that had been transfected with siFLCN#1 was also confirmed by real-time PCR
analysis (data not shown). The asterisks indicate nonspecific bands of the primary antibody.
Figure 7. A proposed model of Rab35 functional cascades in PODXL trafficking under 2D and 3D culture conditions. Rab35 activation during PODXL
trafficking is regulated by distinct Rab35–GEF proteins, depending on the culture conditions (i.e. DENND1A in 3D and FLCN in 2D culture conditions, respec-
tively). DENND1A activates Rab35 and enables it to recruit a Rab35 effector, ACAP2 (Arf6-GAP), in 3D cell cultures. On the other hand, FLCN activates Rab35 and
enables it to recruit another Rab35 effector, OCRL (phosphatidylinositol 4,5-bisphosphate phosphatase), in 2D cell cultures, followed by PODXL apical traffick-
ing (6).
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polyclonal antibody (OriGene, #TA309661), anti-Rab35 rabbit
polyclonal antibody (Proteintech, #11329-2-AP), horseradish
peroxidase (HRP)-conjugated anti-mouse IgG goat polyclonal
antibody (SouthernBiotech, #1031-05), HRP-conjugated anti-
rabbit IgG donkey antibody (GE Healthcare, #NA934-1ML),
Alexa Fluor 488 – conjugated anti-rabbit IgG goat polyclonal
antibody (Thermo Fisher Scientific, #A11034), and Alexa Fluor
Plus 555– conjugated anti-rabbit IgG goat polyclonal antibody
(Thermo Fisher Scientific, #A32732). Alexa Fluor 568 – and
633– conjugated phalloidin were purchased from Thermo
Fisher Scientific (#A12380 and #A22284, respectively).
Plasmid construction
The single guide RNA (sgRNA)- and Cas9-encoding vector
was constructed by using the pSpCas9(BB)-2A-Puro vector
(33). The target sequences against canine DENND1A,
DENND1B, and DENND1C were chosen using the web tool
CRISPRdirect (Table S1) (34).
The standard plasmid used in the real-time PCR analysis was
constructed from the pGEM-T-EASY vector (Promega) as fol-
lows. Partial cDNA fragments of DENND1A, DENND1B, and
DENND1C were amplified from the cDNA library of MDCK II
cells (see “RNA isolation, reverse transcription, and real-time
PCR”) using specific primers (Table S1), and each cDNA was
subcloned into the pGEM-T-EASY vector. The DENND1B and
DENND1C cDNA fragments were then excised by PstI/SphI
and SphI/BstXI, respectively, and were together ligated to the
PstI/BstXI-digested pGEM-T-DENND1A vector to obtain the
standard plasmid (named pGEM-T-DENND1A-1B-1C).
The pMRX-IRES-puro retrovirus vector was kindly donated
by Dr. Shoji Yamaoka (Tokyo Medical and Dental University,
Tokyo, Japan) (35), and Myc, EGFP, or mStr tag was inserted
and/or a puromycin resistance gene (puro) was replaced by a
blasticidin S resistance gene (bsr) to obtain pMRX-bsr-Myc,
pMRX-puro-EGFP, and pMRX-bsr-mStr vectors (7). cDNAs
encoding mouse Rab35 (NM_198163.1; WT, QL, and SN)
(36 –38), mouse DENND1A (NM_001362973.1) (39), hu-
man DENND1B (XM_005244931.2), human DENND1C
(NM_024898.4) (40), and mouse FLCN (NM_001271356.1)
were subcloned into the pMRX-puro-EGFP vector. cDNAs
encoding DENND1A (WT, DENN (lacking amino acids
1–378), and DENN (amino acids 1–378)) and FLCN were sub-
cloned into the pMRX-bsr-Myc vector. cDNAs encoding
DENND1B/1A chimera (amino acids 1–372 of human
DENND1B  amino acids 376 –1059 of mouse DENND1A)
and DENND1C/1A chimera (amino acids 1–393 of human
DENND1C  amino acids 374 –1059 of mouse DENND1A)
were prepared by two-step PCR techniques (41) using specific
primers (Table S1). cDNAs encoding mouse FLCN and mouse
CLC (clathrin light chain) (NM_001080384.3) were subcloned
into the pMRX-bsr-mStr vector.
To achieve low expression levels of exogenous DENND1
proteins, which were comparable with those of endogenous
ones, 6FLAG-tagged DENND1A–C (or DENND1 chimera)
were fused downstream of the bsr and internal ribosome
entry site (IRES) sequences. In addition, the WT IRES
sequence was replaced by a largely truncated IRES sequence
(from 620 to 832 of the encephalomyocarditis virus genome
(NC_001479.1)), resulting in the pMRX-bsr-IRES(620)-
6FLAG-DENND1A–C (or DENND1 chimera) vectors.
Cell cultures
MDCK II cells were grown in culture medium (Dulbecco’s
modified Eagle’s medium; Fujifilm Wako Pure Chemical,
Osaka, Japan) supplemented with 10% fetal bovine serum, pen-
icillin G (100 units/ml), and streptomycin (100 g/ml) at 37 °C
under 5% CO2. For the 2D cell culture observation, the cells
were trypsinized to create a single-cell suspension, 1  105 cells
were plated on an uncoated glass-bottom dish (35-mm dish;
MatTek), and the cells were incubated for 3 h. For the 3D cell
culture observation, the cells were trypsinized to create a sin-
gle-cell suspension, 2  104 cells were plated on a Matrigel
(growth factor–reduced; BD Biosciences)-coated coverglass in
a well of a 24-well plate, and the cells were incubated in a culture
medium containing 2% Matrigel for 42 h. The Plat-E cells were
kindly donated by Dr. Toshio Kitamura (University of Tokyo)
and were grown in the same culture medium and then used for
retrovirus production.
RNA isolation, reverse transcription, and real-time PCR
Total RNA was isolated from parental MDCK II cells (100%
confluent in a 60-mm dish) with TRI reagent (Sigma-Aldrich),
followed by chloroform extraction and 2-propanol precipita-
tion. Reverse transcription was performed using ReverTra Ace
(Toyobo, Osaka, Japan) with 5 g of the total RNA as a template
and oligo(dT) primer. Real-time PCR was performed with the
LightCycler 480 system (Roche, Basel, Switzerland) and TB
GreenTM Premix Ex TaqTM II (Tli RNaseH plus) kit (Takara Bio
Inc., Shiga, Japan). The reaction mixture (final volume: 20 l
including 1 l of template DNA (the standard plasmid or the
reverse transcription product)) was prepared according to
the manufacturer’s instructions. The primers for canine
DENND1A, DENND1B, and DENND1C were designed using
LightCycler Probe Design Software 2.0 (Idaho Technology Inc.)
(Table S1). The real-time PCR was performed using a shuttle
PCR standard protocol, including 40 cycles of denaturation at
95 °C for 5 s and annealing/extension at 60 °C for 30 s, accord-
ing to the manufacturer’s instructions. Experiments were per-
formed by using three independent cDNA samples, each of
which was measured twice and averaged. The relative expres-
sion level of each mRNA was calculated using the known
amount of the standard plasmid (pGEM-T-DENND1A-1B-1C)
described above.
Establishment of KO cells
MDCK II cells (1  105 cells/6-cm dish) were cultured over-
night and were transfected with the sgRNA/Cas9-encoding
plasmid using Lipofectamine 2000 (Thermo Fisher Scientific).
In the case of DENND1A-KO, two distinct sgRNAs were used
simultaneously to induce deletions between the two target sites.
One day after transfection, the medium was changed and a
fresh one was applied, and the cells were cultured for one addi-
tional day. The transfected cells were selected with 2 g/ml
puromycin (Merck) for 24 h. The cells were then cloned by
limiting dilution, and each clone was checked for target gene
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disruption using genomic PCR followed by the sequencing of its
product (42) (see Fig. S2C). The loss of DENND1A protein
expression in DENND1A-KO cells was also checked using
immunoblotting. Rab35-KO cell lines (#18 and #20) were pre-
pared as described previously (6).
Genomic PCR and direct sequencing
Cells were lysed with a digesting buffer (0.5% SDS, 100 mM
NaCl, 10 mM Tris-HCl, pH 8.0, 25 mM EDTA, pH 8.0, and 0.1
mg/ml proteinase K) and gently agitated overnight at 50 °C. An
equal volume of phenol/chloroform was added to the lysate,
followed by vortexing and then centrifugation at 1,700  g for 5
min at room temperature. Genomic DNA in the supernatant
was ethanol-precipitated and subjected to a PCR. A genomic
region containing the target sequence was amplified with LA
Taq or Ex Taq (Takara Bio Inc.) and appropriate pairs of prim-
ers (Table S1), and the products were directly sequenced using
either of the primers.
Retrovirus production and establishment of stable expression
cell lines
For retrovirus production, Plat-E cells (43) (5  105 cells/
35-mm dish coated with poly-L-lysine) were cultured overnight
and were transfected with 2 g of pMRX plasmids together
with 1 g of pLP-VSVG (Thermo Fisher Scientific) using Lipo-
fectamine 2000. One day after transfection, the medium was
changed with a fresh one, and the cells were cultured for one
additional day. The medium was collected and centrifuged at
17,800  g for 2 min to remove debris. The virus-containing
supernatant was used for subsequent viral infection. To estab-
lish stable cell lines, MDCK II cells (1.5  104 cells/35-mm dish)
were cultured overnight, and a retrovirus-containing medium
was added to the culture medium in the presence of 8 g/ml
Polybrene. One day after the addition of the virus, the medium
was changed, and a fresh one without the virus was applied; the
cells were then cultured for one additional day. The infected
cells were selected using 3– 6 g/ml puromycin for 24 h or 13
g/ml blasticidin S (Fujifilm Wako Pure Chemical) for 48 h.
Knockdown experiments
MDCK II cells (2  104 cells/well of a 6-well plate) were
cultured overnight and transfected with 12.5 nM control siRNA
or siRNA against Rab35 or FLCN (#1 or #2) using Lipo-
fectamine RNAiMAX (Thermo Fisher Scientific). Three days
after transfection, the cells for 2D cell cultures were replated for
immunofluorescence analysis or were lysed for immunoblot-
ting. For 3D cell cultures, the cells were cultured in the Matri-
gel-containing medium for 42 h as described above, and 12.5 nM
each of siRNAs and Lipofectamine RNAiMAX were also added
to the medium (6). The siRNAs used in this study are listed in
Table S1.
Immunofluorescence
Immunofluorescence staining of 2D and 3D MDCK II cell
cultures was performed essentially as described previously (6,
44). In brief, the cells were fixed with 4% paraformaldehyde for
10 min (2D) or 30 min (3D), permeabilized with 0.3% Triton
X-100 in PBS for 2 min (2D) or 30 min (3D), and blocked with a
blocking buffer (1% BSA and 0.1% Triton X-100 in PBS) for 15
min (2D) or 30 min (3D). The cells were incubated for 1 h (2D)
or overnight (3D) in a blocking buffer containing the primary
antibody against PODXL (1:2,000 dilution), followed by incu-
bation with a secondary antibody and DAPI for 1 h. For actin
staining, the cells were incubated with Alexa Fluor– conjugated
phalloidin (1:1,000 dilution) together with the secondary anti-
body and DAPI. All of the steps were performed at room
temperature.
Quantification of KO phenotypes in 2D and 3D MDCK cell
cultures
For the 2D cell cultures, 30 cells at the one-cell stage in xz
images were observed in each experiment. Cells in which endo-
somal PODXL was co-localized with actin were manually
counted (see Fig. 1A, PODXL with actin). For the 3D cell cul-
tures, 30 cysts containing 3– 6 cells/cyst in xy-confocal images
were observed in each experiment. Cysts in which PODXL was
localized to the outer membrane were also manually counted.
Cysts containing at least one cell that showed PODXL in the
outer membrane were counted as “inverted PODXL” (see Fig.
1A, Inverted PODXL).
Immunoblotting
Denatured proteins in an SDS sample buffer (62.5 mM Tris-
HCl, pH 6.8, 2% 2-mercaptoethanol, 2% SDS, 10% glycerol, and
0.02% bromphenol blue) were separated using SDS-PAGE and
were transferred to polyvinylidene difluoride membranes
(Merck Millipore). The membranes were blocked with a block-
ing buffer (1% skim milk and 0.1% Tween 20 in PBS) for 15 min
and were incubated for 1 h at room temperature or overnight at
4 °C in the blocking buffer containing appropriate primary anti-
bodies. The membranes were washed three times with 0.1%
Tween 20 containing PBS and were subsequently incubated in
the blocking buffer containing appropriate HRP-conjugated
secondary antibodies. Chemiluminescence signals were
detected using an ECL substrate (Bio-Rad) and a chemilumi-
nescence imager (ChemiDoc Touch, Bio-Rad).
Statistical analysis
The statistical analysis was performed using Tukey’s test or
Dunnett’s test on R software, and the following significance
levels were used: *, p  0.05; **, p  0.01; and ***, p  0.001.
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